Overview

Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a new Gabapentin tablet, is safe and effective for the treatment of painful diabetic peripheral neuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Depomed
Treatments:
Gabapentin
gamma-Aminobutyric Acid